Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue

Autor: Ellen Vercauteren, Andrea Jane Lisgo, Tine Meyer, Michael Power, Ben Chaffey, Torben Steiniche, John Simpson, Angela Silmon, Philip Sloan, Liam Little, Anna Long, Louise Johnston

Publikováno v: Johnston, L, Power, M, Sloan, P, Long, A, Silmon, A, Chaffey, B, Lisgo, A J, Little, L, Vercauteren, E, Steiniche, T, Meyer, T & Simpson, J 2018, ' Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue ', Journal of Clinical Pathology, vol. 71, no. 4, pp. 336-343 . https://doi.org/10.1136/jclinpath-2017-204629
Journal of Clinical Pathology

AimsUnderstanding the molecular mechanisms of underlying disease has led to a movement away from the one-drug-fits-all paradigm towards treatment tailored to the genetic profile of the patient. The Biocartis Idylla platform is a novel fully automated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed765e49a57f788fb15216223e40700
https://doi.org/10.1136/jclinpath-2017-204629